{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:30:33Z","timestamp":1776353433667,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ejpn.2014.11.001","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T16:30:10Z","timestamp":1416241810000},"page":"143-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Retention rates of levetiraceram in Chinese children and adolescents with epilepsy"],"prefix":"10.1016","volume":"19","author":[{"given":"Xue-fei","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2014.11.001_bib1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1046\/j.1528-1157.2001.0420081094.x","article-title":"ILAE\/IBE\/WHO global campaign \u201cout of the shadows\u201d: global and regional developments","volume":"42","author":"Reynolds","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.11.001_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0404.2006.00657.x","article-title":"Levetiracetam: a long-term follow-up study of efficacy and safety","volume":"114","author":"Bauer","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ejpn.2014.11.001_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(06)68182-8","article-title":"Epilepsy in children","volume":"367","author":"Guerrini","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2014.11.001_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.yebeh.2006.12.005","article-title":"Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability","volume":"10","author":"Simister","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ejpn.2014.11.001_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jnnp.2005.064626","article-title":"The long term retention of levetiracetam in a large cohort of patients with epilepsy","volume":"77","author":"Depondt","year":"2006","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ejpn.2014.11.001_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1527-3458.2007.00005.x","article-title":"Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug","volume":"13","author":"De Smedt","year":"2007","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.ejpn.2014.11.001_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuropharm.2007.11.021","article-title":"SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy","volume":"54","author":"Kaminski","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejpn.2014.11.001_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-1211(02)00250-4","article-title":"Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials","volume":"53","author":"Perucca","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ejpn.2014.11.001_bib9","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1528-1157.2000.tb00165.x","article-title":"Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy","volume":"41","author":"Lhatoo","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.11.001_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1528-1167.2011.03300.x","article-title":"Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study","volume":"53","author":"Delanty","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.11.001_bib11","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.clinthera.2010.09.017","article-title":"Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks","volume":"32","author":"Pina-Garza","year":"2010","journal-title":"Clin Ther"},{"issue":"Suppl. 9","key":"10.1016\/j.ejpn.2014.11.001_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1528-1167.2005.00324.x","article-title":"Practical management issues for idiopathic generalized epilepsies","volume":"46","author":"Benbadis","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.11.001_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199002083220604","article-title":"Phenobarbital for febrile seizures \u2013 effects on intelligence and on seizure recurrence","volume":"322","author":"Farwell","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejpn.2014.11.001_bib14","first-page":"27","article-title":"Valproate (depakine chrono) in adult patients with partial epilepsy: results of a multicentral prospective non-comparative study","volume":"112","author":"Gekht","year":"2012","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"10.1016\/j.ejpn.2014.11.001_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.seizure.2012.08.001","article-title":"Polycystic ovary syndrome in patients with epilepsy: a study in 102 Chinese women","volume":"21","author":"Zhou","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2014.11.001_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0404.2009.01257.x","article-title":"Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up","volume":"121","author":"Kuba","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ejpn.2014.11.001_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1059-1311(02)00258-3","article-title":"Clinical experience of marketed levetiracetam in an epilepsy clinic-a one year follow up study","volume":"12","author":"Betts","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2014.11.001_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0404.2008.01062.x","article-title":"Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study","volume":"119","author":"Peltola","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ejpn.2014.11.001_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1017\/S0317167100010283","article-title":"Levetiracetam in clinical practice: efficacy and tolerability in epilepsy","volume":"37","author":"Bilo","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.ejpn.2014.11.001_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0317167100010283","article-title":"Efficacy and tolerability of levetiracetam in children with epilepsy","volume":"33","author":"Li","year":"2011","journal-title":"Brain Dev"},{"key":"10.1016\/j.ejpn.2014.11.001_bib21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1212\/01.wnl.0000279379.32754.8b","article-title":"Response of infantile spasms to levetiracetam","volume":"70","author":"Mikati","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2014.11.001_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejpn.2007.02.016","article-title":"Long-term use of levetiracetam in patients with severe childhood-onset epilepsy","volume":"11","author":"von Stuelpnagel","year":"2007","journal-title":"Europ J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2014.11.001_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eplepsyres.2009.02.016","article-title":"Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies","volume":"85","author":"Rosenfeld","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ejpn.2014.11.001_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.seizure.2010.12.015","article-title":"The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study","volume":"20","author":"Werhahn","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2014.11.001_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejpn.2012.10.008","article-title":"Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram \u2013 a pilot study","volume":"17","author":"Goldberg-Stern","year":"2013","journal-title":"Europ J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2014.11.001_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pediatrneurol.2009.08.002","article-title":"Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy","volume":"42","author":"Lee","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2014.11.001_bib27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3988\/jcn.2011.7.3.128","article-title":"Psychiatric symptoms and quality of life in patients with drug-refractory epilepsy receiving adjunctive levetiracetam therapy","volume":"7","author":"Lee","year":"2011","journal-title":"J Clin Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.ejpn.2014.11.001_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2006.00683.x","article-title":"The effect of antiepileptic drugs on cognition: patient perceived cognitive problems of topiramate versus levetiracetam in clinical practice","volume":"47","author":"Bootsma","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.11.001_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1684\/epd.2008.0227","article-title":"Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study","volume":"10","author":"Lopez-Gongora","year":"2008","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.ejpn.2014.11.001_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yebeh.2009.08.026","article-title":"Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study","volume":"16","author":"Wu","year":"2009","journal-title":"Epilepsy Behav"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814001767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814001767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T03:42:07Z","timestamp":1717558927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379814001767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1090379814001767"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.11.001","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retention rates of levetiraceram in Chinese children and adolescents with epilepsy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}